Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. (ALLO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ALLO · as of Jun 8, 2026
Key Statistics
Explore Allogene Therapeutics, Inc. Data
allo stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 30 · Buy rate: 63.3%
The ALLO analyst consensus is Buy, based on ratings from 30 Wall Street analysts over the past 3 months. The average 12-month price target is $6.43, representing +242.02% upside from the current price of $1.88.
Competitors & Peers
allo competitorsALLO
ACHV
AVIR
CABA
CRBU
EDITStock Performance
Full HistoryAbout Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufact…
what is allogene therapeutics, inc. · allo stock overview · allogene therapeutics, inc. company profile · who is allogene therapeutics, inc. ceo · allo NASDAQ · allogene therapeutics, inc. headquarters · allogene therapeutics, inc. business segments
About Stock Overview & Key Data
Allogene Therapeutics, Inc. (ALLO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 11, 2018. As of the latest trading session, ALLO stock price is $1.88, with a market capitalization of $458.5M. The stock has returned +33.33% over the past 12 months and +37.23% year-to-date.
According to 30 Wall Street analysts, the consensus rating for Allogene Therapeutics, Inc. stock is Buy, with an average 12-month price target of $6.43. In fiscal year 2025, Allogene Therapeutics, Inc. reported revenue of — and net income of -$190.9M. For detailed data — including Allogene Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Allogene Therapeutics, Inc. (ALLO) stock price is $1.88. The stock is traded on NASDAQ under the ticker symbol ALLO. The 52-week range is $0.98 – $4.46.